# Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis

> **NCT06535542** · NA · RECRUITING · sponsor: **Abu Dhabi Health Services Company** · enrollment: 40 (estimated)

## Conditions studied

- Hypercholesterolemia, Autosomal Dominant
- Hypercholesterolemia, Autosomal Recessive
- Familial Combined Hypercholesterolemia

## Interventions

- **GENETIC:** Whole Genome Sequencing

## Key facts

- **NCT ID:** NCT06535542
- **Lead sponsor:** Abu Dhabi Health Services Company
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-29
- **Primary completion:** 2025-12-15
- **Final completion:** 2026-07-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06535542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06535542, "Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06535542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*